Skandinaviska Enskilda Banken AB publ bought a new stake in Medtronic PLC (NYSE:MDT) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 234,746 shares of the medical technology company’s stock, valued at approximately $23,092,000.

Other large investors have also recently modified their holdings of the company. Point72 Asset Management L.P. raised its holdings in Medtronic by 11.1% in the 2nd quarter. Point72 Asset Management L.P. now owns 823,622 shares of the medical technology company’s stock valued at $70,510,000 after acquiring an additional 82,423 shares during the period. Affiance Financial LLC raised its holdings in Medtronic by 18.6% in the 2nd quarter. Affiance Financial LLC now owns 8,080 shares of the medical technology company’s stock valued at $692,000 after acquiring an additional 1,268 shares during the period. Royal London Asset Management Ltd. bought a new position in Medtronic in the 2nd quarter valued at about $49,276,000. First Hawaiian Bank bought a new position in Medtronic in the 3rd quarter valued at about $3,143,000. Finally, WINTON GROUP Ltd raised its holdings in Medtronic by 60.2% in the 2nd quarter. WINTON GROUP Ltd now owns 99,746 shares of the medical technology company’s stock valued at $8,539,000 after acquiring an additional 37,482 shares during the period. Institutional investors and hedge funds own 80.00% of the company’s stock.

MDT has been the topic of several research analyst reports. Zacks Investment Research raised shares of Medtronic from a “hold” rating to a “buy” rating and set a $105.00 price target on the stock in a report on Tuesday, October 23rd. ValuEngine raised shares of Medtronic from a “hold” rating to a “buy” rating in a report on Friday, September 7th. Citigroup increased their price target on shares of Medtronic from $104.00 to $109.00 and gave the company a “buy” rating in a report on Friday, August 24th. SunTrust Banks increased their price target on shares of Medtronic to $110.00 and gave the company a “buy” rating in a report on Friday, August 24th. Finally, Argus raised their target price on shares of Medtronic from $108.00 to $120.00 and gave the stock a “buy” rating in a report on Monday, October 8th. Seven research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average price target of $102.58.

Shares of MDT opened at $94.36 on Friday. Medtronic PLC has a 12 month low of $76.41 and a 12 month high of $100.15. The company has a market cap of $127.11 billion, a PE ratio of 19.49, a price-to-earnings-growth ratio of 2.50 and a beta of 0.94. The company has a current ratio of 2.46, a quick ratio of 2.06 and a debt-to-equity ratio of 0.47.

Medtronic (NYSE:MDT) last announced its earnings results on Tuesday, August 21st. The medical technology company reported $1.17 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.11 by $0.06. Medtronic had a net margin of 10.56% and a return on equity of 12.98%. The company had revenue of $7.38 billion for the quarter, compared to analysts’ expectations of $7.24 billion. During the same period last year, the firm earned $1.12 earnings per share. The business’s revenue for the quarter was down .1% on a year-over-year basis. As a group, equities analysts predict that Medtronic PLC will post 5.12 EPS for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 19th. Investors of record on Friday, September 28th were paid a $0.50 dividend. The ex-dividend date of this dividend was Thursday, September 27th. This represents a $2.00 dividend on an annualized basis and a yield of 2.12%. Medtronic’s dividend payout ratio (DPR) is 41.93%.

In related news, EVP Geoffrey Martha sold 49,799 shares of Medtronic stock in a transaction that occurred on Monday, September 24th. The shares were sold at an average price of $97.93, for a total value of $4,876,816.07. Following the transaction, the executive vice president now directly owns 87,872 shares of the company’s stock, valued at $8,605,304.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Richard H. Anderson acquired 2,600 shares of the firm’s stock in a transaction that occurred on Thursday, August 23rd. The stock was purchased at an average cost of $95.88 per share, for a total transaction of $249,288.00. The disclosure for this purchase can be found here. Insiders sold 268,678 shares of company stock worth $25,818,353 over the last three months. 0.28% of the stock is currently owned by insiders.

ILLEGAL ACTIVITY NOTICE: “234,746 Shares in Medtronic PLC (MDT) Acquired by Skandinaviska Enskilda Banken AB publ” was first posted by Daily Political and is owned by of Daily Political. If you are reading this piece of content on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://www.dailypolitical.com/2018/11/10/234746-shares-in-medtronic-plc-mdt-acquired-by-skandinaviska-enskilda-banken-ab-publ.html.

Medtronic Company Profile

Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group.

Read More: How to Invest in a Bull Market

Institutional Ownership by Quarter for Medtronic (NYSE:MDT)

Receive News & Ratings for Medtronic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic and related companies with MarketBeat.com's FREE daily email newsletter.